RNA dimerization defect in a rous sarcoma virus matrix mutant

Journal of Virology

Volumn 74, Issue 1, 2000, Pages 164-172

  Parent, Leslie J ^a   Cairns, Tina M ^a   Albert, Jessica A ^a   Wilson, Carol B ^a   Wills, John W ^a   Craven, Rebecca C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; MATRIX PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; DIMERIZATION; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; RNA STRUCTURE; ROUS SARCOMA ONCOVIRUS; SEQUENCE ANALYSIS;

EID: 0033986876     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.1.164-172.2000     Document Type: Article

References (63)

1. Aronoff, R., A. M. Hajjar, and M. L. Linial. 1993. Avian retroviral encapsidation: reexamination of functional 5′ RNA sequences and the role of the nucleucapsid Cys-His motifs. J. Virol. 67:178-188.
2. Aronoff, R., and M. L. Linial. 1991. Specificity of retroviral packaging. J. Virol. 65:71-80.
3. Bennett, R. B., and J. W. Wills. 1999. Conditions for copackaging Rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding. J. Virol. 73:2045-2051.
4. Bennett, R. P., T. D. Nelle, and J. W. Wills. 1993. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 67:6487-6498.
5. Berkowitz, R., J. Fisher, and S. P. Goff. 1996. RNA packaging, p. 177-218. In H.-G. Krausslich (ed.), Morphogenesis and maturation of retroviruses. Springer-Verlag, Berlin, Germany.
6. Bieth, E., C. Gabus, and J.-L. Darlix. 1990. A study of the dimer formation of Rous sarcoma virus RNA and its effect on viral protein synthesis in vitro. Nucleic Acids Res. 18:119-127.
7. Boone, L. R., and A. Skalka. 1980. Two species of full-length cDNA are synthesized in high yield by melittin-treated avian retrovirus particles. Proc. Natl. Acad. Sci. USA 77:847-851.
8. Boone, L. R., and A. M. Skalka. 1981. Viral DNA synthesis in vitro by avian retrovirus particles permeabilized with melittin. J. Virol. 37:109-116.
9. Bowles, N. E., P. Damay, and P.-F. Spahr. 1993. Effects of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67:623-631.
10. Buss, J. E., M. P. Kamps, and B. M. Sefton. 1984. Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Mol. Cell. Biol. 4:2697-2704.
11. Cannon, P. M., S. Matthews, N. Clark, E. D. Byles, O. Iourin, D. J. Hockley, S. Kingsman, and A. J. Kingsman. 1997. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J. Virol. 71:3474-3483.
12. Carriere, C., B. Gay, N. Chazal, N. Morin, and P. Boulanger. 1995. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles. J. Virol. 69:2366-2377.
13. Casella, C. R., L. J. Raffinni, and A. T. Panganiban. 1997. Pleotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. Virology 228:294-306.
14. Christensen, A. M., M. A. Massiah, B. G. Turner, W. I. Sundquist, and M. F. Summers. 1996. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses. J. Mol. Biol. 264:1117-1131.
15. Craven, R. C., A. E. Leure-duPree, R. A. Weldon, and J. W. Wills. 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69:4213-4227.
16. Crawford, S., and S. P. Goff. 1984. Mutations in gag proteins P12 and P15 of Moloney leukemia virus block early stages of infection. J. Virol. 49:909-917.
17. sjc myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4:1834-1842.
18. Dong, J., J. W. Dubay, L. G. Perez, and E. Hunter. 1992. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J. Virol. 66:865-874.
19. Dupraz, P., S. Oertle, C. Meric, P. Damay, and P. F. Spahr. 1990. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein. J. Virol. 64:4978-4987.
20. Erdie, C. R., and J. W. Wills. 1990. Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells. J. Virol. 64:5204-5208.
21. Fosse, P., N. Motte, A. Roumier, C. Gabus, D. Muriaux, J. L. Darlix, and J. Paoletti. 1996. A short autocomplementary sequence plays an essential role in avian sarcoma-leukosis virus RNA dimerization. Biochemistry 35:16601-16609.
22. Franke, E. K., H. E. H. Yuan, K. L. Bossolt, S. P. Goff, and J. Luban. 1994. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 68:5300-5305.
23. Freed, E. O., G. Englund, and M. A. Martin. 1995. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69:3949-3954.
24. Fu, W., R. Gorelick, and A. Rein. 1994. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-deficient virions. J. Virol. 68:5013-5018.
25. Fu, W., and A. Rein. 1993. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67:5443-5449.
26. Gorelick, R., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
27. Gottlinger, H. G., T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1991. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 88:3195-3199.
28. Hill, C. P., D. Worthylake, D. P. Bancroft, A. M. Christensen, and W. I. Sundquist. 1996. Crystal structure of the trimeric human immunodeficiency virus type 1 matrix protein. Proc. Natl. Acad. Sci. USA 93:3099-3104.
29. Hirt, B. 1967. Selective extraction of polyomavirus DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
30. src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 14:4625-4628.
31. Katz, R. A., R. W. Terry, and A. Skalka. 1986. A conserved cis-acting sequence in the 5′ leader of avian sarcoma virus RNA is required for packaging. J. Virol. 59:163-167.
32. Kiernan, R. E., A. Ono, G. Englund, and E. O. Freed. 1998. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72:4116-4126.
33. Kunkel, T. A., K. Bebenek, and J. McClary. 1991. Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol. 204:125-139.
34. Lai, M. M. 1976. Phosphoproteins of Rous sarcoma viruses. Virology 74: 287-301.
35. Lear, A. L., M. Haddrick, and S. Heapy. 1995. A study of the dimerization of Rous sarcoma virus RNA in vitro and in vivo. Virology 212:47-57.
36. + T lymphocytes. J. Virol. 71:1443-1452.
37. Mammano, F., E. Kondo, J. G. Sodroski, A. Bukovsky, and H. G. Gottlinger. 1995. Rescue of human immunodeficiency virus type 1 matrix mutants by envelope glycoproteins with short cytoplasmic tails. J. Virol. 69:3824-3830.
38. Matthews, S., M. Mikhailov, A. Burny, and P. Roy. 1996. The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins. EMBO J. 15:3267-3274.
39. McDonnell, J. M., C. B. Wilson, W. Zhou, A. Wolven, T. D. Nelle, J. W. Wills, M. D. Resh, and D. Cowburn. 1998. Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J. Mol. Biol. 279: 921-928.
40. Meric, C., E. Gouilloud, and P.-F. Spahr. 1988. Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes. J. Virol. 62:3328-3333.
41. Moscovici, C., M. G. Moscovici, H. Jimenez, M. M. C. Lai, M. J. Hayman, and P. K. Vogt. 1977. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell 11:95-103.
42. Murti, K. G., M. Boundurant, and A. Tereba. 1981. Secondary structural features in the 70S RNAs of Moloney murine leukemia virus and Rous sarcoma virus as observed by electron microscopy. J. Virol. 37:411-419.
43. Nelle, T. D., M. F. Verderame, J. Leis, and J. W. Wills. 1998. The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication. J. Virol. 72:1103-1107.
44. Nelle, T. D., and J. W. Wills. 1996. A large region within the Rous sarcoma virus matrix protein dispensable for budding and infectivity. J. Virol. 70: 2269-2276.
45. Parent, L. J., C. B. Wilson, M. D. Resh, and J. W. Wills. 1996. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J. Virol. 70:1016-1026.
46. src can direct myristylation and plasma membrane localization when fused to heterologous proteins. Nature (London) 346:84-86.
47. Perez, L. G., G. L. Davis, and E. Hunter. 1987. Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions. J. Virol. 61:2981-2988.
48. Reicin, A., A. Ohagen, L. Yin, S. Hoglund, and S. P. Goff. 1996. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps in the replication cycle. J. Virol. 70:8645-8652.
49. Resh, M. D., and H. P. Ling. 1990. Identification of a 32K plasma membrane protein that binds to the myristylated amino-terminal sequence of p60v-src. Nature (London) 346:84-86.
50. Sakalian, M., J. W. Wills, and V. M. Vogt. 1994. Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. J. Virol. 68:5969-5981.
51. Sorge, J., W. Ricci, and S. H. Hughes. 1983. cis-acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus. J. Virol. 48:667-675.
52. gag) of avian sarcoma and leukemia viruses. J. Virol. 64:847-855.
53. Stoltzfus, C. M., and P. N. Snyder. 1975. Structure of B77 sarcoma virus RNA: stabilization of RNA after packaging. J. Virol. 16:1161-1170.
54. Swanstrom, R., and J. W. Wills. 1997. Synthesis, assembly, and processing of retroviral proteins, p. 263-334. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
55. Verderame, M. F., T. D. Nelle, and J. W. Wills. 1996. The membrane-binding domain of the Rous sarcoma virus Gag protein. J. Virol. 70:2664-2668.
56. Weldon, R. A., Jr., C. R. Erdie, M. G. Oliver, and J. W. Wills. 1990. Incorporation of chimeric Gag protein into retroviral particles. J. Virol. 64:4169-4179.
57. Weldon, R. A., Jr., and J. W. Wills. 1993. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release. J. Virol. 67:5550-5561.
58. Wills, J. W., C. E. Cameron, C. B. Wilson, Y. Xiang, R. P. Bennett, and J. Leis. 1994. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 68:6605-6618.
59. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral Gag proteins. AIDS 5:639-654.
60. Wills, J. W., R. C. Craven, and J. A. Achacoso. 1989. Creation and expression of myristylated forms of Rous sarcoma virus Gag protein in mammalian cells. J. Virol. 63:4331-4343.
61. Young, J. A. T., P. Bates, K. Willert, and H. E. Varmus. 1990. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 250:1421-1423.
62. Yu, X., X. Yuan, Z. Matsuda, T.-H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral enveloped protein into mature virions. J. Virol. 66:4966-4971.
63. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.